|
ELK4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.651530E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.923000E-01 |
| Normal-vs-Stage2 |
1.895410E-01 |
| Normal-vs-Stage3 |
5.717800E-03 |
| Normal-vs-Stage4 |
1.560290E-03 |
| Stage1-vs-Stage2 |
5.469200E-01 |
| Stage1-vs-Stage3 |
4.735600E-02 |
| Stage1-vs-Stage4 |
1.493790E-02 |
| Stage2-vs-Stage3 |
4.000800E-01 |
| Stage2-vs-Stage4 |
1.777430E-01 |
| Stage3-vs-Stage4 |
5.046800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.147700E-02 |
| Normal-vs-AfricanAmerican |
2.363400E-04 |
| Normal-vs-Asian |
5.195200E-01 |
| Caucasian-vs-AfricanAmerican |
9.196800E-03 |
| Caucasian-vs-Asian |
1.731430E-01 |
| AfricanAmerican-vs-Asian |
2.112000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.842300E-03 |
| Normal-vs-Female |
1.383550E-01 |
| Male-vs-Female |
3.058200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.385800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.046000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.821000E-03 |
| Normal-vs-Age(81-100Yrs) |
9.321800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.180400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.304600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.835400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.528100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.959000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.931600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.703400E-01 |
| Normal-vs-Grade 2 |
2.215200E-01 |
| Normal-vs-Grade 3 |
8.699000E-03 |
| Normal-vs-Grade 4 |
7.979400E-03 |
| Grade 1-vs-Grade 2 |
3.641200E-01 |
| Grade 1-vs-Grade 3 |
1.395000E-01 |
| Grade 1-vs-Grade 4 |
9.413900E-02 |
| Grade 2-vs-Grade 3 |
1.237610E-01 |
| Grade 2-vs-Grade 4 |
5.987600E-02 |
| Grade 3-vs-Grade 4 |
4.218000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.986000E-01 |
| Normal-vs-ccB subtype |
2.238100E-02 |
| ccA subtype-vs-ccB subtype |
5.122800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.012220E-01 |
| Normal-vs-N1 |
9.270800E-01 |
| N0-vs-N1 |
4.560600E-01 |
|
|
